Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (6): 1033-1038. doi: 10.19723/j.issn.1671-167X.2018.06.016
• Article • Previous Articles Next Articles
Jie-yu GU1,Cui LU2,Hui SHI1,Cheng-de YANG1,△()
CLC Number:
[1] |
Miyakis S, Lockshin MD, Atsumi T , et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J]. J Thromb Haemost, 2006,4(2):295-306.
doi: 10.1111/jth.2006.4.issue-2 |
[2] |
Asherson RA , Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome:international consensus statement on classification criteria and treatment guidelines[J]. Lupus, 2003,12(7):530-534.
doi: 10.1191/0961203303lu394oa pmid: 12892393 |
[3] |
Cervera R, Serrano R, Pons-Estel GJ , et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period:a multicentre prospective study of 1000 patients[J]. Ann Rheum Dis, 2015,74(6):1011-1018.
doi: 10.1136/annrheumdis-2013-204838 pmid: 24464962 |
[4] |
Espinosa G, Bucciarelli S, Cervera R , et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies[J]. Ann Rheum Dis, 2004,63(6):730-736.
doi: 10.1136/ard.2003.007245 pmid: 1755024 |
[5] |
Cervera R, Rodriguez-Pinto I, Colafrancesco S , et al. 14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome[J]. Autoimmun Rev, 2014,13(7):699-707.
doi: 10.1016/j.autrev.2014.03.002 |
[6] |
Rodriguez-Pinto I, Moitinho M, Santacreu I , et al. Catastrophic antiphospholipid syndrome (CAPS):Descriptive analysis of 500 patients from the International CAPS Registry[J]. Autoimmun Rev, 2016,15(12):1120-1124.
doi: 10.1016/j.autrev.2016.09.010 pmid: 27639837 |
[7] |
Ortega-Hernandez OD, Agmon-Levin N, Blank M , et al. The physiopathology of the catastrophic antiphospholipid (Asherson’s) syndrome: compelling evidence[J]. J Autoimmun, 2009,32(1):1-6.
doi: 10.1016/j.jaut.2008.10.003 pmid: 19059760 |
[8] |
Giannakopoulos B, Krilis SA . The pathogenesis of the antiphospholipid syndrome[J]. N Engl J Med, 2013,368(11):1033-1044.
doi: 10.1056/NEJMra1112830 pmid: 23484830 |
[9] |
Agmon-Levin N, Rosario C, Katz BS , et al. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)[J]. Lupus, 2013,22(13):1327-1335.
doi: 10.1177/0961203313504633 pmid: 24036580 |
[10] |
Bakhtar O, Thajudeen B, Braunhut BL , et al. A case of thrombotic microangiopathy associated with antiphospholipid antibody syndrome successfully treated with eculizumab[J]. Transplantation, 2014,98(3):e17-18.
doi: 10.1097/TP.0000000000000267 pmid: 25089339 |
[11] |
Wig S, Chan M, Thachil J , et al. A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor[J]. Rheumatology (Oxford), 2016,55(2):382-384.
doi: 10.1093/rheumatology/kev371 pmid: 26472567 |
[12] |
Cervera R, Font J, Gomez-Puerta JA , et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome[J]. Ann Rheum Dis, 2005,64(8):1205-1209.
doi: 10.1136/ard.2004.025759 pmid: 15708888 |
[1] | Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283. |
[2] | Qing PENG,Jia-jun LIU,Yan LIU,Hua SHANG,Guo TANG,Ya-xin HAN,Li LONG. Application of Padua prediction score and serum albumin level in evaluating venous thromboembolism in rheumatic inpatients [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 625-630. |
[3] | Yu-ke HOU,Qing-meng CAI,Xiang-jun LIU,Ze-lin YUN,Chun LI,Xue-wu ZHANG. Clinical significance of oxidized low-density lipoprotein antibody in antiphospholipid syndrome [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1117-1122. |
[4] | Feng-yun-zhi ZHU,Xiao-yan XING,Xiao-fei TANG,Yi-min LI,Miao SHAO,Xue-Wu ZHANG,Yu-hui LI,Xiao-lin SUN,Jing HE. Clinical and immunological characteristics of myositis complicated with thromboembolism [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 995-1000. |
[5] | Zhi-gang ZHANG,Xin-min LIU. Clinical characteristics of patients with acute renal infarction: an analysis of 52 patients in a single center [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 863-869. |
[6] | Wei ZHANG,Pei-xun ZHANG. Analysis of prophylactic effect of extended-duration anticoagulant drugs in elderly patients undergoing hip fracture [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 501-504. |
|